Rubus parviflorus (Thimbleberry)

Thimbleberry (Rubus parviflorus) is a wild-harvested North American berry containing anthocyanins and ellagitannins that exert antioxidant activity primarily through free radical scavenging and inhibition of lipid peroxidation. No human clinical trials have specifically studied R. parviflorus, so its health effects are extrapolated from related Rubus species research.

Origin & History

Rubus parviflorus (thimbleberry) is a deciduous shrub in the Rosaceae family native to western North America, from Alaska to California and east to the Great Lakes region. It produces edible red berries from the Rubus genus, with fruits, leaves, and stems traditionally harvested wild rather than cultivated. The plant lacks specific extraction methods documented for R. parviflorus, though general Rubus species yield phenolic-rich extracts via solvent methods.

Historical & Cultural Context

Rubus parviflorus berries and leaves have been used by Indigenous North American peoples for food and minor medicinal purposes, including as a poultice for wounds or digestive aid. The broader Rubus genus features in European and Asian traditional systems for diarrhea, uterine health, inflammation, and infections, with R. idaeus leaves used as astringents for centuries.

Health Benefits

• No specific health benefits for R. parviflorus are clinically documented - evidence quality: absent
• Related Rubus species show potential for menopause symptom relief based on one RCT with R. coreanus - evidence quality: preliminary
• Genus-wide antioxidant properties suggested from in vitro studies on phenolic compounds - evidence quality: preliminary
• Traditional use for wound healing and digestive support by Indigenous peoples - evidence quality: traditional only
• Potential anti-inflammatory effects inferred from related Rubus species - evidence quality: preliminary

How It Works

Thimbleberry's primary bioactive compounds — anthocyanins such as cyanidin-3-glucoside and ellagitannins including sanguiin H-6 — neutralize reactive oxygen species (ROS) by donating hydrogen atoms to free radicals, inhibiting lipid peroxidation via suppression of NADPH oxidase activity. Ellagitannins are metabolized by gut microbiota into urolithins, which may modulate NF-κB signaling pathways to reduce pro-inflammatory cytokine expression including TNF-α and IL-6. Polyphenolic constituents may also weakly interact with estrogen receptors (ERα and ERβ), a mechanism proposed for menopausal symptom relief observed in related species such as R. coreanus.

Scientific Research

No human clinical trials, RCTs, or meta-analyses specifically on Rubus parviflorus were found in the research. The only related clinical evidence comes from one RCT (PMID: 35251207) testing Rubus coreanus extract combined with Astragalus membranaceus in 72 postmenopausal women, showing reduced menopause symptoms over 12 weeks.

Clinical Summary

No randomized controlled trials or observational studies have been conducted specifically on Rubus parviflorus in human subjects, leaving its clinical evidence base absent. The closest relevant human trial is a single RCT investigating R. coreanus extract for menopausal symptoms, which reported a statistically significant reduction in Kupperman Index scores compared to placebo, though sample size and blinding details limit generalizability. In vitro studies on Rubus genus extracts demonstrate IC50 values for DPPH radical scavenging in the range of 10–50 µg/mL, suggesting meaningful antioxidant capacity, but these results do not translate directly to clinical outcomes. Until species-specific human trials are conducted, any health claims for thimbleberry remain speculative and extrapolated from genus-level data.

Nutritional Profile

Rubus parviflorus (Thimbleberry) nutritional data is primarily derived from fruit composition analysis, with limited published quantitative studies specific to this species. Fresh thimbleberry fruit contains approximately 85-88% water, with carbohydrates as the dominant macronutrient (~10-12g/100g fresh weight), primarily as simple sugars (fructose and glucose) and dietary fiber (~4-6g/100g, predominantly insoluble cellulose and pectin). Protein content is low (~0.8-1.2g/100g), and fat is negligible (<0.5g/100g). Vitamin C content is estimated at 15-30mg/100g based on extrapolation from closely related Rubus species such as R. idaeus (red raspberry), though direct measurement data for R. parviflorus is sparse. Vitamin K and folate are present at minor levels consistent with other Rubus berries. Mineral content includes potassium (~150-200mg/100g estimated), manganese (~0.3-0.6mg/100g), magnesium, and calcium at modest concentrations. The most characterized bioactive compounds are polyphenols: ellagitannins (including ellagic acid, estimated 10-50mg/100g fresh weight by analogy to congeners), anthocyanins (cyanidin-3-glucoside and cyanidin-3-rutinoside as likely dominant forms, estimated 50-150mg/100g), and flavonols such as quercetin glycosides. Leaves contain tannins and flavonoids used traditionally; specific concentrations are undocumented for this species. Bioavailability of ellagitannins is low in native form but gut microbiota convert them to bioavailable urolithins; anthocyanin bioavailability is generally <5% in humans. All quantitative values should be treated as estimates pending species-specific analytical studies.

Preparation & Dosage

No clinically studied dosages exist for Rubus parviflorus due to absent human trials. Related Rubus coreanus extract was studied at 2000 mg/day (oral, combined with A. membranaceus) for 12 weeks, though this cannot be extrapolated to thimbleberry. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Astragalus membranaceus, other Rubus species, antioxidant polyphenols, vitamin C, quercetin

Safety & Interactions

Thimbleberry is generally regarded as safe when consumed as a whole food, with no documented serious adverse events in the published literature specific to R. parviflorus. Individuals with known allergies to Rosaceae family plants, including raspberries or blackberries, should exercise caution due to potential cross-reactivity involving shared allergenic proteins. The ellagitannin and polyphenol content theoretically could inhibit CYP3A4 enzyme activity at high concentrated extract doses, potentially altering plasma levels of medications metabolized by this pathway such as statins or certain anticoagulants, though no interaction studies have confirmed this for R. parviflorus specifically. Pregnant and breastfeeding women should limit use beyond normal food amounts, as the weak phytoestrogenic activity observed in related Rubus species has not been assessed for reproductive safety in this species.